Inherited thrombophilia genes in minorities

Genetic Testing

Volumn 3, Issue 4, 1999, Pages 371-373

  Mack, Richard ^a   Chowdary, Dondapati ^a   Streck, Deanna ^a   Dermody, James ^a  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); BLOOD CLOTTING FACTOR 5 LEIDEN; PROTHROMBIN;

ARTICLE; CAUCASIAN; CHINESE; CONTROLLED STUDY; GENE ISOLATION; GENE MUTATION; GENETIC PREDISPOSITION; HUMAN; MINORITY GROUP; NEGRO; THROMBOPHILIA;

EID: 0033429006     PISSN: 10906576     EISSN: None     Source Type: Journal    
DOI: 10.1089/gte.1999.3.371     Document Type: Article

References (10)

1. ADCOCK, D.M., FINK, L., and MARLAR, R.A. (1997). A laboratory approach to the evaluation of hereditary hypercoagulability. Am. J. Clin. Pathol. 108, 434-449.
2. BERTINA, R.M., KOELEMAN, B.P.C., KOSTER, T., ROSENDAAL, F.R., DIRVEN, R.J., DE RONDE, H., VAN DER VELDEN, P.A., and REITSMA, P.H. (1994). Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 369, 64-67.
3. FROSST, P., BLOM, H.J., MILOS, R., GOYETTE, P., SHEPPARD, C.A., MATTHEWS, R.G., BOERS, G.J.H., DEN HEUER, M., KLUIJTMANS, L.A.J., VAN DEN HEUVEL, L.P., and ROZEN, R. (1995). A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nature Genet. 10, 111-113.
4. KAHN, M.J., SCHER, C., ROZANS, M., MICHAELS, R.K., LEISSINGER, C., and KRAUSE, J. (1997). Factor V Leiden is not responsible for stroke in patients with sickling disorder and is uncommon in African Americans with sickle cell disease. Am. J. Hematol. 54, 12-15.
5. MACK, R., SAMAAN, P., PODOLAK, I., and ALBANESE, E. (1998). Prevalence of Factor V Leiden in Afro-Americans. Res. Commun. Mol. Pathol. Pharmacol. 99, 339-344.
6. POORT, S.R., ROSENDAAL, F.R., REITSMA, P.H., and BERTINA, R.M. (1996). A common genetic variation in the 3′-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood 88, 3698-3703.
7. POTTINGER, P., SIGURDSSON, F., and BERLINER, N. (1996). Detection of Factor V Leiden mutation in a nonselected black population. Blood 87, 2091.
8. REES, D.C., COX, M., and CLEGG, J.B. (1995). World distribution of Factor V Leiden. Lancet 346, 1133-1134.
9. REUNER, K.H., RULF, A., GRAU, A., et al. (1998). Prothrombin gene G20210A transition is a risk factor for cerebral venous thrombosis. Stroke 29, 1765-1769.
10. WRIGHT, J.G., COOPER, P., MALIA, R.G., KULOZIK, A.E., VETTER, B., THOMAS, P., PRESTON, F.E., and SERJEANT, G.R. (1997). Activated protein C resistance in homozygous sickle cell disease. Br. J. Haematol. 96, 854-856.